Gaviscon

Sodium alginate, sodium bicarbonate, calcium carbonate.

Gaviscon contains sodium alginate, sodium bicarbonate and calcium carbonate in the following strengths: See table.

Click on icon to see table/diagram/image

Gaviscon chewable tablet is aluminum-, sugar-, lactose- and gluten-free. Gaviscon oral suspension is sugar-free and gluten-free.

Sodium alginate reacts with gastric HCl to produce a low density viscous raft that floats on top of the stomach contents to physically impede their reflux back into the esophagus. Thus, the acid pepsin, bile and food all remain in the stomach.
The bicarbonate reacts with the HCl to produce bubbles of carbon dioxide that become entrapped in the raft allowing it to float on the stomach contents. The inclusion of calcium carbonate in some formulations means that the raft has considerable strength, since a cross-linked lattice is formed involving calcium ions released on reaction of calcium carbonate with HCl and the guluronate dimers in the alginic acid. The raft remains on top of the stomach contents until the stomach empties.

Gaviscon brings fast, soothing and long lasting relief. It is used for the treatment of symptoms of gastroesophageal reflux (GERD) eg, acid regurgitation, heartburn due to reflux of stomach content. It is safe for pregnant women and breastfeeding mothers.

Chewable Tablet: Adults and Children >12 years: 2-4 tablets. The tablet must be chewed thoroughly before swallowing.
Oral Suspension: Adults and Children >12 years: Take 10-20 mL (two to four 5 mL spoonfuls). Administered after meals and at bedtime.

Hypersensitivity to any of the ingredients of Gaviscon as very rare difficulty in breathing and skin rashes have occurred.

Chewable Tablet: Store below 30°C. Oral Suspension: Store at room temperature not exceeding 30°C.
Shelf-Life: 2 years.

Antacids, Antireflux Agents & Antiulcerants

A02A - ANTACIDS ; Used in the treatment of acid-related disorders.

Non-Rx